We are live on
!
Find out more
LSA
L & S Advisors Portfolio holdings
AUM
$967M
1-Year Est. Return
68.8%
This Fund
S&P 500
This Quarter
Est. Return
+7.56%
1 Year Est. Return
+68.8%
3 Year Est. Return
+231.28%
5 Year Est. Return
+398.69%
10 Year Est. Return
+2,093.99%
AUM
$653M
AUM Growth
+$54.9M
(+9.2%)
Cap. Flow
-$43.1M
Cap. Flow
% of AUM
-6.61%
Top 10 Holdings %
Top 10 Hldgs %
20.66%
Holding
339
New
53
Increased
78
Reduced
80
Closed
28
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$7.15M |
| 2 |
Stanley Black & Decker
SWK
|
+$6.05M |
| 3 |
DXC Technology
DXC
|
+$5.85M |
| 4 |
EOG Resources
EOG
|
+$5.75M |
| 5 |
RSPP
RSP Permian, Inc.
RSPP
|
+$5.69M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$7.17M |
| 2 |
UnitedHealth
UNH
|
+$6.28M |
| 3 |
JB Hunt Transport Services
JBHT
|
+$6.08M |
| 4 |
Baxter International
BAX
|
+$5.62M |
| 5 |
Johnson & Johnson
JNJ
|
+$5.62M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 28.15% |
| 2 | Technology | 15.59% |
| 3 | Industrials | 13.59% |
| 4 | Energy | 8.91% |
| 5 | Financials | 8.88% |
Similar funds
IECM
SWM
DCM
RWM
RWP
BST
NI
MWM
L & S Advisors's Q4 2017 Portfolio in Review
As of Q4 2017, L & S Advisors held 339 positions worth $653M, up 9.2% from $598M the previous quarter. Its ten largest holdings account for 21% of the portfolio.
L & S Advisors withdrew a net $43.1M in Q4 2017, closing 28 positions and reducing 80 holdings. Its most notable exit was Gilead Sciences, an estimated $7.17M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, down from 28% a quarter earlier, followed by Technology and Industrials.
Against the trend, L & S Advisors opened a new position in Royal Dutch Shell PLC ADS Class A worth $7.57M.
- L & S Advisors's largest Q4 2017 buy was Royal Dutch Shell PLC ADS Class A: 113,470 shares worth $7.57M.
- L & S Advisors added most to EOG Resources in Q4 2017, an estimated $5.75M increase.
- L & S Advisors's biggest Q4 2017 reduction was UnitedHealth, cutting an estimated $6.28M.
- L & S Advisors fully exited Gilead Sciences in Q4 2017, selling an estimated $7.17M.
- L & S Advisors's ten largest holdings make up 21% of its $653M portfolio in Q4 2017.
- L & S Advisors opened 53 new positions and closed 28 in Q4 2017.
- L & S Advisors's portfolio value rose 9.2% quarter-over-quarter to $653M.
Based on L & S Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.